Abstract
The lung cancer treatment landscape has substantially changed in the last decade with novel treatment options available for subsets of lung cancer. With these treatment advances, many patients receive multiple lines of therapies, including clinical trials as a potential option. Our current knowledge of how patients are diagnosed, and how they access and experience treatments is limited to clinical trials and single-institution studies. Project PEER (Understanding the lung cancer Patient ExperiEnce in the Real-world setting), a collaborative endeavor between LUNGevity Foundation and FDA-OCE (Oncology Centers of Excellence), aims to systematically understand how lung cancer patients feel and function during treatment and whether this experience is affected by their specific diagnosis and treatment options.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
